TKNONasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Alpha Teknova, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$6.80−0.28 (-3.95%)
Close on Oct 19, 2026
- Market cap
- $364.72M
- P/E (TTM)
- –
- Dividend yield
- –
Alpha Teknova statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of In Vitro & In Vivo Diagnostic Substances companies for comparison
Valuation
| Measure | Alpha Teknova | Industry median |
|---|---|---|
| Market Cap | $365.08M | $197.05M |
| Enterprise Value | $347.64M | $106.56M |
| PS Ratio | 8.35 | 3.93 |
| PB Ratio | 5.83 | 2.14 |
| P/TBV Ratio | 7.13 | 2.46 |
Enterprise value
| Measure | Alpha Teknova | Industry median |
|---|---|---|
| EV / Sales | 7.96 | 2.69 |
Income (trailing twelve months)
| Measure | Alpha Teknova | Industry median |
|---|---|---|
| Revenue | $43.70M | $57.94M |
| Gross Profit | $15.12M | $90.47M |
| Operating Income | -$15.81M | -$21.44M |
| Pretax Income | -$16.68M | -$14.45M |
| Net Income | -$16.77M | -$22.46M |
| EBITDA | -$9.47M | -$16.91M |
| EPS (Diluted) | -$0.31 | -$0.83 |
Margins
| Measure | Alpha Teknova | Industry median |
|---|---|---|
| Gross Margin | 34.6% | 52.3% |
| Operating Margin | -36.2% | -44.5% |
| Pretax Margin | -38.2% | -13.0% |
| Profit Margin | -38.4% | -39.2% |
| EBITDA Margin | -21.7% | -31.3% |
| FCF Margin | -16.8% | -8.85% |
Returns
| Measure | Alpha Teknova | Industry median |
|---|---|---|
| Return on Equity (ROE) | -24.2% | -53.1% |
| Return on Assets (ROA) | -16.3% | -41.0% |
| Return on Invested Capital (ROIC) | -25.7% | -32.0% |
| Return on Capital Employed (ROCE) | -17.8% | -37.8% |
Growth
| Measure | Alpha Teknova | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 12.3% | 6.01% |
| Revenue Growth (3Y CAGR) | -0.73% | 2.25% |
| Revenue Growth (5Y CAGR) | 5.30% | 6.42% |
Balance sheet
| Measure | Alpha Teknova | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $17.44M | $62.42M |
| Net Cash (Debt) | $17.44M | $15.68M |
| Net Cash Per Share | $0.32 | $0.65 |
| Equity (Book Value) | $62.60M | $48.79M |
| Book Value Per Share | $1.17 | $1.36 |
| Tangible Book Value | $51.23M | $23.06M |
| Working Capital | $23.95M | $75.77M |
Financial position
| Measure | Alpha Teknova | Industry median |
|---|---|---|
| Current Ratio | 4.49 | 3.30 |
| Quick Ratio | 3.32 | 2.39 |
Cash flow (trailing twelve months)
| Measure | Alpha Teknova | Industry median |
|---|---|---|
| Operating Cash Flow | -$6.27M | -$12.35M |
| Capital Expenditures | -$1.08M | -$1.06M |
| Free Cash Flow | -$7.35M | -$20.28M |
| FCF Per Share | -$0.14 | -$0.41 |
Efficiency
| Measure | Alpha Teknova | Industry median |
|---|---|---|
| Asset Turnover | 0.42 | 0.38 |
| Inventory Turnover | 3.94 | 2.67 |
| Revenue Per Employee | $276.58K | $398.96K |
| Profits Per Employee | -$106.13K | -$732.08K |
| Employee Count | 158 | 73 |
Dividends and yields
| Measure | Alpha Teknova | Industry median |
|---|---|---|
| Earnings Yield | -4.59% | -21.2% |
| FCF Yield | -2.01% | -7.64% |
Shares
| Measure | Alpha Teknova | Industry median |
|---|---|---|
| Shares Outstanding | 53,688,200 | 59,128,900 |
| Shares Change (YoY) | 1.03% | 11.1% |
| Shares Change (QoQ) | 0.14% | 0.54% |
| Float | 52,987,400 | 48,744,500 |
| Shares Held by Insiders | 1.31% | 11.8% |
| Shares Held by Institutions | 17.0% | 59.4% |
Taxes
| Measure | Alpha Teknova | Industry median |
|---|---|---|
| Income Tax | $94.00K | $91.50K |
Scores
| Measure | Alpha Teknova | Industry median |
|---|---|---|
| Altman Z-Score | 4.70 | 0.10 |
| Piotroski F-Score | 6 | 4 |
| Beneish M-Score | -2.92 | -2.62 |
Calculated by StockData from Alpha Teknova's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.